TY - JOUR
T1 - Proteasome gene expression is controlled by coordinated functions of multiple transcription factors
AU - Gilda, Jennifer E.
AU - Nahar, Asrafun
AU - Kasiviswanathan, Dharanibalan
AU - Tropp, Nadav
AU - Gilinski, Tamar
AU - Lahav, Tamar
AU - Alexandrovich, Dina
AU - Mandel-Gutfreund, Yael
AU - Park, Soyeon
AU - Shemer, Shenhav
N1 - Publisher Copyright:
© 2024 Gilda et al.
PY - 2024/8/5
Y1 - 2024/8/5
N2 - Proteasome activity is crucial for cellular integrity, but how tissues adjust proteasome content in response to catabolic stimuli is uncertain. Here, we demonstrate that transcriptional coordination by multiple transcription factors is required to increase proteasome content and activate proteolysis in catabolic states. Using denervated mouse muscle as a model system for accelerated proteolysis in vivo, we reveal that a two-phase transcriptional program activates genes encoding proteasome subunits and assembly chaperones to boost an increase in proteasome content. Initially, gene induction is necessary to maintain basal proteasome levels, and in a more delayed phase (7–10 days after denervation), it stimulates proteasome assembly to meet cellular demand for excessive proteolysis. Intriguingly, the transcription factors PAX4 and α-PALNRF-1 control the expression of proteasome among other genes in a combinatorial manner, driving cellular adaptation to muscle denervation. Consequently, PAX4 and α-PALNRF-1 represent new therapeutic targets to inhibit proteolysis in catabolic diseases (e.g., type-2 diabetes, cancer).
AB - Proteasome activity is crucial for cellular integrity, but how tissues adjust proteasome content in response to catabolic stimuli is uncertain. Here, we demonstrate that transcriptional coordination by multiple transcription factors is required to increase proteasome content and activate proteolysis in catabolic states. Using denervated mouse muscle as a model system for accelerated proteolysis in vivo, we reveal that a two-phase transcriptional program activates genes encoding proteasome subunits and assembly chaperones to boost an increase in proteasome content. Initially, gene induction is necessary to maintain basal proteasome levels, and in a more delayed phase (7–10 days after denervation), it stimulates proteasome assembly to meet cellular demand for excessive proteolysis. Intriguingly, the transcription factors PAX4 and α-PALNRF-1 control the expression of proteasome among other genes in a combinatorial manner, driving cellular adaptation to muscle denervation. Consequently, PAX4 and α-PALNRF-1 represent new therapeutic targets to inhibit proteolysis in catabolic diseases (e.g., type-2 diabetes, cancer).
UR - http://www.scopus.com/inward/record.url?scp=85193675148&partnerID=8YFLogxK
U2 - 10.1083/jcb.202402046
DO - 10.1083/jcb.202402046
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38767572
AN - SCOPUS:85193675148
SN - 0021-9525
VL - 223
JO - Journal of Cell Biology
JF - Journal of Cell Biology
IS - 8
M1 - e202402046
ER -